Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Austin Eakin-Love"'
Autor:
Jack Patrick Gleeson, Fergus Keane, Niamh M. Keegan, Emin Mammadov, Emily Harrold, Abdullah Alhusaini, Jeffrey Harte, Austin Eakin‐Love, Philip J. O'Halloran, Stephen MacNally, Bryan T. Hennessy, Oscar S. Breathnach, Liam Grogan, Patrick G. Morris
Publikováno v:
Cancer Medicine, Vol 9, Iss 2, Pp 469-475 (2020)
Abstract Introduction Bevacizumab has demonstrated activity in glioblastoma (GBM), but the true benefits and optimal dose‐schedule are debated. A lower dose‐schedule than standard‐dose bevacizumab (10 mg/kg 2‐weekly) might offer similar benef
Externí odkaz:
https://doaj.org/article/7160152b75c84accabe1ca9133765361
Autor:
Austin Eakin-Love, Niamh M. Keegan, Fergus Keane, Liam Grogan, Jeffrey Harte, Stephen MacNally, Philip J. O’Halloran, Emin Mammadov, Abdullah Alhusaini, Jack Patrick Gleeson, Emily Harrold, Patrick G. Morris, Oscar S. Breathnach, Bryan T. Hennessy
Publikováno v:
Cancer Medicine, Vol 9, Iss 2, Pp 469-475 (2020)
Cancer Medicine
Cancer Medicine
Introduction Bevacizumab has demonstrated activity in glioblastoma (GBM), but the true benefits and optimal dose‐schedule are debated. A lower dose‐schedule than standard‐dose bevacizumab (10 mg/kg 2‐weekly) might offer similar benefits with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b770bd35e1d2d32da917587b0decf776
https://doaj.org/article/7160152b75c84accabe1ca9133765361
https://doaj.org/article/7160152b75c84accabe1ca9133765361